Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Pfizer/BioNTech submit data to EMA for COVID-19 vaccine in young children

Published 10/15/2021, 09:54 AM
Updated 10/15/2021, 10:08 AM
© Reuters. FILE PHOTO: Pharmacist Susanne Wohlgemuth prepares Pfizer/BioNTech COVID-19 vaccinations at the Haus an der Linde nursing home in Lichtentanne, Saxony, Germany December 27, 2020, the day when the country starts its vaccination programme. Hendrik Schmidt/P

(Reuters) -Pfizer Inc and German partner BioNTech SE (NASDAQ:BNTX) said on Friday that they had submitted data supporting the use of their COVID-19 vaccine in children aged between five and less than 12 years to the European Medicines Agency.

Although the vaccine is currently not allowed for that age group, it has been authorized for use in children over 12 years of age in both the United States and the European Union.

The companies earlier this month asked U.S. regulators to also grant emergency use authorization of the shot for young children, and an advisory panel to the U.S. Food and Drug Administration is expected to meet next month to review the data.

While children are less susceptible to severe COVID-19, they can spread the virus to others, including vulnerable populations more at risk of severe illness.

The Pfizer/BioNTech vaccine has been shown to induce a strong immune response in five to 11 year olds in a 2,268-participant clinical trial, the companies said on Sept. 20.

Latest comments

Watch for more broken hearts...literally.
Gavin Newsom kids are not vaccinated but yet he wants to force your children. Think about it
Children have lowest risk to Covid, you could argue the vaccine side effects could be greater than the benefit since after all there are no long term studies.
Why do you need children vaccinated? Health is more importsnt that your earning you greedy pos
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.